AstraZeneca has earned the Employer of the Year title at the 2026 Neurodiverse Business Awards, in honor of its significant dedication to neuroinclusion.
The global biopharmaceutical company received praise for its clear and sustained commitment to attracting, retaining and supporting neurodivergent colleagues. Judges emphasized AstraZeneca’s extensive strategy, which includes its global TH!NK Neurodiversity programme and a strong Neurodiversity Employee Resource Group.
The Neurodiverse Business Awards commend organizations that embrace neurological differences as a strategic advantage, recognizing the distinct skills and viewpoints neurodivergent individuals contribute to the workplace. AstraZeneca’s award confirms its position as a leader in developing an inclusive environment, providing a strong model for large employers worldwide on how to translate commitment into significant, long-term positive change.
Congratulations to AstraZeneca on this well-earned recognition, which demonstrates the strength and innovation that stems from a diverse workforce!